Hands-Free ELISA and High-precision Microfluidic Immunoassays by Integrating Correlia Biosystems Modules with the OT-2



Plate-based immunoassays are the workhorse of protein quantification, but these decades-old methods require tedious manual intervention, have limited dynamic range, require relatively large (50-100 μL) sample volume, and have long assay times.


Correlia offers two platforms that overcome bottlenecks of traditional ELISA.  The PIXI immunoassay platform enables highly efficient protein measurements from as little as 1 microliter of starting sample volume, while the Correlia Aspirator Arm enables running standard ELISA plates with full hands-free automation. In this webinar, we describe how both user-friendly systems can be integrated with an OT-2 robot, and show case studies demonstrating efficient measurements of a variety of protein targets. 


Correlia Biosystems won the 2020 Society for Laboratory Automation and Screening IGNITE Award for Best Startup, and their technology has now serviced 5 of the top 15 global pharma companies.




Sign up to receive this 60-minute webinar to learn:

  • Advantages of the highly efficient PIXI platform including extended dynamic range, hands-free workflow, and microsample immunoassay capabilities
  • Case studies of automated microscale and conventional ELISA for drug development and diagnostic applications
  • How to add immunoassay and liquid aspiration capabilities to your OT-2 robots       

Access the Webinar Now

Subject to your consent given above, by clicking on “Get the Webinar”, Opentrons and Correlia Biosystems may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.



unnamed Samuel Tia

Chief Science Officer, Correlia Biosystems







Samuel Tia is co-founder of Correlia Biosystems and works to expand Correlia’s test menu and immunoassay capabilities to deliver solutions for customer proteomic applications. Dr. Tia received a PhD in Bioengineering from UC Berkeley, where his work in the Herr lab led to a licensed patent. He has a BS in Mechanical Engineering from the University of Florida, and previous industry experience in drug delivery and medical device manufacturing.


Originally Aired 08/03/22